Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals-Reference-Cited by-同舟云学术

Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals

Published:2018-03-27 Issue:6 Volume:32 Page:739-749
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Justice Amy C.,Gordon Kirsha S.,Skanderson Melissa,Edelman Eva Jennifer,Akgün Kathleen M.,Gibert Cynthia L.,Lo Re Vincent,Rimland David,Womack Julie A.,Wyatt Christina M.,Tate Janet P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference29 articles.

1. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes;Gnjidic;J Clin Epidemiol,2012

2. Clinical outcomes associated with medication regimen complexity in older people: a systematic review;Wimmer;J Am Geriatr Soc,2017

3. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review;Saedder;Br J Clin Pharmacol,2015

4. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population;Holtzman;J Gen Intern Med,2013

5. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients;Tseng;Ann Pharmacother,2013

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Immunodeficiency Virus in Older Adults;Clinics in Geriatric Medicine;2024-05

2. Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV;HIV Medicine;2024-01-23

3. Healthy aging: Linking causal mechanisms with holistic outcomes;Aging Cell;2023-12-18

4. An overview of multimorbidity and polypharmacy in older people living with HIV;Geriatrics & Gerontology International;2023-11-08

5. Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project;Revista Española de Quimioterapia;2023-09-19